Article
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
How AI Is Already Reshaping Cancer Care
When treating cancer, few things are more precious than time. Jeanine Bortel, Vice President and Head of AI Portfolio Development at Pfizer, who has developed clinical trials at Pfizer for more than two decades, remembers when she first witnessed the transformative potential of artificial intelligence (AI) put into practice to help address the needs of patients enrolled in cancer clinical trials.For years, Bortel’s work had run up against an inherent challenge: Many cancer patients miss out on...
Ever Wonder How Medicines Get Their Names?
Naming a medicine is more than just a creative exercise. It’s a critical, complicated, and collaborative step in bringing innovative treatments to patients.Some medicine names may sound unfamiliar, but there’s a lot of intention behind every syllable. Long before a treatment reaches patients, its name goes through a careful, highly regulated process designed to help prevent confusion and support safe use in real world healthcare settings.From early lab identifiers to globally recognized generic...
March Social Media Round-Up—2025 Annual Review, World’s Most Ethical Companies, and More
Spring has sprung! At Pfizer, we’re celebrating the changing seasons with exciting updates across our social channels.This March, we received another accolade (Ethisphere recognized Pfizer as one of the World’s Most Ethical Companies for the fifth year in a row), shared new episodes of “Science Will Win” and “What’s In My Lab”, and provided a behind-the-scenes look at our commitment to fighting cancer.We also published our 2025 Annual Review, with opening remarks from CEO Albert Bourla, while...
Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection
For many people living with transthyretin amyloid cardiomyopathy (ATTR‑CM) – a rare and underdiagnosed cause of heart failure – receiving an accurate diagnosis can be a long and uncertain journey.1,2 Symptoms often resemble more common heart conditions, and early clues are easy to miss.1 But, new real-world evidence being shared at the American College of Cardiology (ACC) Scientific Sessions highlights opportunities to raise suspicion earlier in the diagnostic journey.“Many patients are already...
As Colorectal Cancer Rises in Younger Populations, Research and Education is More Important than Ever
At one time, colorectal cancer was a disease associated with older adults. Now, it’s considered the most deadly cancer in people younger than 50.1Even as deaths from the other most common cancers (breast cancer, lung cancer, brain cancer and leukemia) have fallen by 44% over a 30-year-period, according to the American Cancer Society, colorectal cancer deaths have increased 1.1% per year in younger people since 2005.1 It’s a development that’s alarming—and mystifying—healthcare providers and...
Pfizer Among World’s Most Ethical Companies for 5th Straight Year
Over the weekend, Hollywood celebrated itself at the Academy Awards. As the celebrities and craftspeople present would likely admit, they don’t do what they do to win prizes. Everyone likes a little recognition, but that’s not the driving force behind their work.The same holds true for Pfizer and its employees; we’re in this to make breakthroughs that change patients’ lives, not to take home trophies.That said, we are proud to share some news: for the fifth straight year, Pfizer has been...
CEO Albert Bourla Reflects on Pfizer’s Year of Bold Moves and Relentless Innovation in 2025 Annual Review
2025 was a typically busy year for Pfizer, one of strong performance, disciplined execution and bold moves that position us for future growth and lasting impact for patients around the world as we continue to pursue our mission of making breakthroughs that change people’s lives.The entire organization remained focused on addressing the world’s most pressing health challenges, and 2025 was a year of significant progress toward that goal. We’ve detailed some of the highlights in our latest Annual...
One Pediatric Gastroenterologist’s Mission to Expand Pediatric Treatment Options
For Dr. Nicole Kulisek, the path from pediatric gastroenterologist to US Medical Affairs leader at Pfizer has always been guided by the same question: How can we expand access to effective treatments for children who need them most?From bedside care to drug development, her career reflects a belief that early intervention, paired with scientific rigor, can change the course of a child’s life. Today, that perspective shapes her work at Pfizer, where she helps advance IBD innovations aimed at...
Self -Care for Caregivers
Caregivers play remarkable and invaluable roles in our communities. They support children, parents, grandparents, spouses, neighbors, and friends. They do everything from preparing meals to managing finances to helping with dressing and bathing.1This is generous, loving work, but it can also be taxing on the body and mind. Nearly half of caregivers experience moderate or high physical strain, and about 65% say they experience moderate or high emotional stress.2 This can take a toll on health...
February Social Media Round-Up—World Cancer Day, Science Will Win, and More
The groundhog may have predicted six more weeks of winter, but here at Pfizer we’re predicting blue skies ahead as we wrap up another great month.We kicked off February with the launch of season six of “Science Will Win”—Pfizer’s award-winning podcast, announced the launch of The Empowering Women in IBD Leadership program, shared positive results in an ongoing study in patients with metastatic colorectal cancer, and much more.CEO Albert Bourla celebrated World Cancer Day by highlighting the...
How Innovative Diagnostics Are Supporting a Potential Approach to C. difficile
When scientists design a new vaccine candidate, they must also identify diagnostic tests that can be used to measure how effective that vaccine is. Those tests are often as unique and innovative as the vaccine candidate itself, says Michael Pride, Pfizer’s Vice President, Bacterial Vaccines.“Just as there’s no one-size-fits-all-pathogens vaccine, every diagnostic test is different, depending on the organism you want to detect,” says Pride.Recently, Pfizer developed and validated a test for use...
Behind the Science: A New Path to Tackling Metastatic Breast Cancer
In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease. Breast cancer is one of the most common cancers in women, with about one in eight women in the United States alone diagnosed during their lifetimes.i Metastatic breast cancer, a more advanced and invasive form of the disease, remains a particularly critical area of unmet need...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.